Skip to Content
Merck
CN

SML3038

JB170

≥98% (HPLC)

Synonym(s):

4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-N-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)ethoxy)ethoxy)ethyl)-2-methoxybenzamide, Thalidomide-PEG2-Alisertib

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C48H44ClFN8O11
CAS Number:
2705844-82-0
Molecular Weight:
963.36
UNSPSC Code:
12352107
NACRES:
NA.77

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

GYKNPXCQINZRLL-UHFFFAOYSA-N

SMILES string

O=C1N(C2CCC(NC2=O)=O)C(C3=C1C(OCC(NCCOCCOCCNC(C4=CC=C(NC5=NC(C(C=CC(Cl)=C6)=C6C(C7=C(OC)C=CC=C7F)=NC8)=C8C=N5)C=C4OC)=O)=O)=CC=C3)=O

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (Warmed)

storage temp.

2-8°C

Quality Level

100

Related Categories

Biochem/physiol Actions

JB170 is a highly specific AURORA-A degrader (PROTAC) comprising aurora kinase inhibitor alisertib connected to the CEREBLON-binding molecule thalidomide. JB170 induces rapid and durable degradation of AURORA-A in cancer cells leading to strong S-phase arrest and apoptosis.
highly specific AURORA-A degrader (PROTAC) that induces rapid and durable degradation of AURORA-A in cancer cells

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000157232
0000157232
0000157231
0000147642
0000147642

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bikash Adhikari et al.
Nature chemical biology, 16(11), 1179-1188 (2020-09-30)
The mitotic kinase AURORA-A is essential for cell cycle progression and is considered a priority cancer target. Although the catalytic activity of AURORA-A is essential for its mitotic function, recent reports indicate an additional non-catalytic function, which is difficult to

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service